Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 2
1991 1
1992 1
1996 1
1999 1
2003 3
2006 1
2007 1
2008 3
2009 1
2010 3
2014 1
2016 1
2018 1
2019 1
2020 2
2022 1
2023 1
2024 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Obesity and Sex Affect the Immune Responses to Tick-Borne Encephalitis Booster Vaccination.
Garner-Spitzer E, Poellabauer EM, Wagner A, Guzek A, Zwazl I, Seidl-Friedrich C, Binder CJ, Stiasny K, Kundi M, Wiedermann U. Garner-Spitzer E, et al. Front Immunol. 2020 May 27;11:860. doi: 10.3389/fimmu.2020.00860. eCollection 2020. Front Immunol. 2020. PMID: 32528467 Free PMC article. Clinical Trial.
In order to assess the responsiveness to tick-borne encephalitis (TBE) vaccine, we revaccinated 37 obese individuals and 36 normal-weight controls with a licensed TBE vaccine. ...
In order to assess the responsiveness to tick-borne encephalitis (TBE) vaccine, we revaccinated 37 obese individuals an …
Immunogenicity against Far Eastern and Siberian subtypes of tick-borne encephalitis (TBE) virus elicited by the currently available vaccines based on the European subtype: systematic review and meta-analysis.
Domnich A, Panatto D, Arbuzova EK, Signori A, Avio U, Gasparini R, Amicizia D. Domnich A, et al. Hum Vaccin Immunother. 2014;10(10):2819-33. doi: 10.4161/hv.29984. Hum Vaccin Immunother. 2014. PMID: 25483679 Free PMC article.
Tick-borne encephalitis (TBE) virus, which is usually divided into European, Far Eastern and Siberian subtypes, is a serious public health problem in several European and Asian countries. ...
Tick-borne encephalitis (TBE) virus, which is usually divided into European, Far Eastern and Siberian subtypes, is a se …
Ability of inactivated vaccines based on far-eastern tick-borne encephalitis virus strains to induce humoral immune response in originally seropositive and seronegative recipients.
Maikova GB, Chernokhaeva LL, Rogova YV, Kozlovskaya LI, Kholodilov IS, Romanenko VV, Esyunina MS, Ankudinova AA, Kilyachina AS, Vorovitch MF, Karganova GG. Maikova GB, et al. J Med Virol. 2019 Feb;91(2):190-200. doi: 10.1002/jmv.25316. Epub 2018 Oct 28. J Med Virol. 2019. PMID: 30204244 Clinical Trial.
Tick-borne encephalitis (TBE) remains one of the major public health concerns in northern Eurasia, and its' area is expanding. ...Sera were collected during clinical trials in the TBEV Siberian subtype endemic area. Adult recipients were vaccinated with Ti …
Tick-borne encephalitis (TBE) remains one of the major public health concerns in northern Eurasia, and its' area is exp …
Five accelerated schedules for the tick-borne encephalitis vaccine FSME-Immun in last-minute travellers: an open-label, single-centre, randomized controlled pilot trial.
Berens-Riha N, Andries P, Aerssens A, Ledure Q, Van Der Beken Y, Heyndrickx L, Genbrugge E, Tsoumanis A, Van Herrewege Y, Ariën KK, Van Innis M, Vanbrabant P, Soentjens P; FASTBEPROTECT Research Team. Berens-Riha N, et al. J Travel Med. 2024 Oct 19;31(7):taad053. doi: 10.1093/jtm/taad053. J Travel Med. 2024. PMID: 37074147 Free PMC article. Clinical Trial.
BACKGROUND: The purpose of this exploratory study was to evaluate different accelerated tick-borne encephalitis (TBE) vaccine schedules for last-minute travellers. METHODS: In a single-centre, open-label pilot study, 77 TBE-naive Belgian soldiers were randomi …
BACKGROUND: The purpose of this exploratory study was to evaluate different accelerated tick-borne encephalitis (TBE) v …
Humoral immunity against tick-borne encephalitis virus following manifest disease and active immunization.
Klockmann U, Bock HL, Kwasny H, Praus M, Cihlová V, Tomková E, Krivanec K. Klockmann U, et al. Vaccine. 1991 Jan;9(1):42-6. doi: 10.1016/0264-410x(91)90315-w. Vaccine. 1991. PMID: 2008800 Clinical Trial.
Humoral immunity against tick-borne encephalitis virus (TBEV) in patients with a well-documented history of naturally acquired tick-borne encephalitis (TBE) was compared with immunity resulting from vaccination in a carefully controlled i …
Humoral immunity against tick-borne encephalitis virus (TBEV) in patients with a well-documented history of naturally a …
Safety and immunogenicity of the modified adult tick-borne encephalitis vaccine FSME-IMMUN: results of two large phase 3 clinical studies.
Loew-Baselli A, Konior R, Pavlova BG, Fritsch S, Poellabauer E, Maritsch F, Harmacek P, Krammer M, Barrett PN, Ehrlich HJ; FSME-IMMUN study group. Loew-Baselli A, et al. Vaccine. 2006 Jun 12;24(24):5256-63. doi: 10.1016/j.vaccine.2006.03.061. Epub 2006 Apr 3. Vaccine. 2006. PMID: 16624457 Clinical Trial.
A prospective, randomised, multicentre, single-blind phase 3 study was performed to assess the safety of a vaccination schedule consisting of two vaccinations (21-35 days apart) with the tick-borne encephalitis (TBE) vaccine FSME-IMMUN "adults" (five consecut …
A prospective, randomised, multicentre, single-blind phase 3 study was performed to assess the safety of a vaccination schedule consisting o …
Sustained antibody persistence for at least 15 years after a booster vaccination against tick-borne encephalitis following different primary vaccination schedules: Third 5-year follow-up.
Beran J, Lattanzi M, Costantini M, Pammolli A, Galgani I. Beran J, et al. Vaccine. 2023 May 26;41(23):3518-3524. doi: 10.1016/j.vaccine.2023.04.061. Epub 2023 May 3. Vaccine. 2023. PMID: 37142462 Free article. Clinical Trial.
BACKGROUND: Vaccination is the best mode of protection against tick-borne encephalitis (TBE) and its sequelae. The duration of protection and the optimal interval of repeat booster doses are still debated. ...
BACKGROUND: Vaccination is the best mode of protection against tick-borne encephalitis (TBE) and its sequelae. The dura …
Randomized, phase II dose-finding studies of a modified tick-borne encephalitis vaccine: evaluation of safety and immunogenicity.
Ehrlich HJ, Pavlova BG, Fritsch S, Poellabauer EM, Loew-Baselli A, Obermann-Slupetzky O, Maritsch F, Cil I, Dorner F, Barrett PN. Ehrlich HJ, et al. Vaccine. 2003 Dec 12;22(2):217-23. doi: 10.1016/s0264-410x(03)00563-2. Vaccine. 2003. PMID: 14615149 Clinical Trial.
Two clinical studies were conducted to identify the optimal dose of a modified tick-borne encephalitis (TBE) vaccine (FSME-IMMUN "new") in adults. A prospective, randomised, phase II, double-blind dose-finding study with the FSME-IMMUN "new" vaccine was perfo …
Two clinical studies were conducted to identify the optimal dose of a modified tick-borne encephalitis (TBE) vaccine (F …
A randomized phase II study of a new tick-borne encephalitis vaccine using three different doses and two immunization regimens.
Harabacz I, Bock H, Jüngst C, Klockmann U, Praus M, Weber R. Harabacz I, et al. Vaccine. 1992;10(3):145-50. doi: 10.1016/0264-410x(92)90003-3. Vaccine. 1992. PMID: 1557929 Clinical Trial.
A new, highly purified inactivated tick-borne encephalitis (TBE) vaccine (FSME-Vaccine Behring, BI 71.061) was recently registered in Germany. ...
A new, highly purified inactivated tick-borne encephalitis (TBE) vaccine (FSME-Vaccine Behring, BI 71.061) was recently …
25 results